Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-023402

Chief Executive Officer sold 2,000 shares at $16.13 ($32,252)

  • Chief Executive Officer acquired 2,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Harris Todd · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-03 Exercise or conversion : show line 1 in the form 10b5-1 +2,000 $2.25 $4,500 1,703,276 D
2023-04-03 Sale : show line 2 in the form 10b5-1 −2,000 $16.13 $32,252 1,701,276 D
Open-market sales · 2,000 sh · avg $16.13 · $32,252

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-04-03 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −2,000 397,537 D
Loading xslF345X04/doc4.xml…